|
Presiding Chairs
|
|
Presiding Chair:
|
Girish Gudi, Glenmark Pharmaceuticals, India
|
|
Presiding Chair-Elect:
|
Vinay Shedbalkar, Pharmaedge, India
|
|
Regulated Bioanalysis
|
|
Chair:
Chair-Elect:
|
Vinay Shedbalkar, Pharmaedge, India
Ashutosh Pudage, Accutest, India
|
|
Committee:
|
CT Vishwanathan, CT Vishwanathan & Associates,US Timothy Olah, Bristol-Myers Squibb, US Pathanjali Kadiyala, Bristol-Myers Squibb, US Ashutosh Pudage, Accutest, India Shrinivas Savale, Torrent Pharmaceuticals Ltd, India Manish Yadav, Cadila Pharma, India Viswanathan, Microtherapeutics Research Labs, India Arshad Khuroo, Ranbaxy, India
|
|
Biotransformation
|
|
Chair:
Chair-Elect:
|
Sandhya Mandlekar, Bristol-Myers Squibb, India
Kaushik Mitra, Merck, US
|
|
Committee:
|
Deepak Dalvie, Pfizer, US
Raju Subramanian, Amgen, US
Narendra Kishnani, Briston-Myers Squibb, US
Ravi Rahavendran, Pfizer, US Murali Subramanian, Biocon-Bristol-Myers Squibb Research Centre, India Ventakata Rao, Advinus, India Ravi T, Glenmark, India Sanjeev Giri, Jubiliant, India
|
|
Discovery
|
|
Chair:
Chair-Elect:
|
Vijay Raina, Nektar, India
Jignesh Kotecha, Torrent Research Centre, India
|
|
Committee:
|
Timothy Olah, Bristol-Myers Squibb, US Deepak Barot, Microtherapeutics Research Labs, India Ravi Trivedi, Biocon Bristol-Myers Squibb Research Center, India
Ravi Rahavendran, Pfizer, US
Dan Morgan, Bristol-Myers Squibb, US
Jonathan Josephs, Bristol-Myers Squibb, US Ravishankar M N, Sunpharma, India
|
|
